---
title: "600613.SH (600613.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600613.SH/news.md"
symbol: "600613.SH"
name: "600613.SH"
parent: "https://longbridge.com/en/quote/600613.SH.md"
datetime: "2026-03-13T22:35:37.341Z"
locales:
  - [en](https://longbridge.com/en/quote/600613.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600613.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600613.SH/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/600613.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/600613.SH/news.md)


# 600613.SH (600613.SH) — Related News

### [The concerted action party of Shenqi's controlling shareholder plans to reduce its holdings by no more than 3%](https://longbridge.com/en/news/267805005.md)
*2025-11-28T09:37:03.000Z*
> Shenqi announced that Zhang Zhijun, a concerted actor of the controlling shareholder, plans to reduce his holdings by no

### [Overview of Important Announcements from Listed Companies on November 24th](https://longbridge.com/en/news/267191571.md)
*2025-11-24T13:15:55.000Z*
> On November 24th, multiple listed companies released important announcements: the online issuance of Moore Threads had a

### [Shenqi: Wholly-owned subsidiary pays back taxes and late fees of 16.6712 million yuan](https://longbridge.com/en/news/267135000.md)
*2025-11-24T08:46:31.000Z*
> Shenqi announced that its subsidiary Guizhou Baiqiang Pharmaceutical Co., Ltd. has conducted a self-examination and shou

### [Shenqi's stock price plummets: the company siphons off sales expenses and fabricates accounts receivable repayments](https://longbridge.com/en/news/259252658.md)
*2025-09-29T04:09:16.000Z*
> Shenqi's stock price plummeted due to news of financial fraud, with a decline of over 7% on September 29. The company wa

### [Shenqi: Used the halted "Essential Drug Promotion Plan" project to extract sales expenses of 44.84 million yuan, multiple executives were issued warning letters](https://longbridge.com/en/news/259068919.md)
*2025-09-26T12:27:41.000Z*
> Shenqi Pharmaceuticals misappropriated sales expenses of 44.84 million yuan due to the illegal use of the discontinued "

### [Shanghai Shenqi Pharmaceutical received an administrative supervision measure decision from the Securities Regulatory Commission for information disclosure violations](https://longbridge.com/en/news/259009706.md)
*2025-09-26T08:17:42.000Z*
> Shanghai Shenqi received an administrative supervision decision from the Shanghai Securities Regulatory Bureau for infor

### [Shenqi: Net profit of 32.8081 million yuan in the first half of 2025, a year-on-year decrease of 13.29%](https://longbridge.com/en/news/255154859.md)
*2025-08-29T08:45:30.000Z*
> Shenqi announced that in the first half of 2025, operating income was 961 million yuan, a year-on-year decrease of 13.47

### [Shenqi: Maijisi pledged 26.67 million shares and released 18.259 million shares](https://longbridge.com/en/news/241567491.md)
*2025-05-23T08:17:41.000Z*
> Shenqi announced that shareholder Maijisi pledged 26.67 million shares and released 18.259 million shares. Maijisi holds

### [Shareholder of Shenqi, Zhang Ya, intends to reduce holdings by no more than 1% of shares](https://longbridge.com/en/news/240825552.md)
*2025-05-19T11:19:02.000Z*
> According to the Zhitong Finance APP, Shenqi announced that Zhang Ya, a concerted actor of the controlling shareholder,